| Literature DB >> 24572700 |
Craig Teerlink1, Quentin Nelson1, Randall Burt2, Lisa Cannon-Albright3.
Abstract
OBJECTIVES: The genetic basis of colorectal cancer (CRC) is not completely specified. Part of the difficulty in mapping predisposition genes for CRC may be because of phenotypic heterogeneity. Using data from a population genealogy of Utah record linked to a statewide cancer registry, we identified a subset of CRC cases that exhibited familial clustering in excess of that expected for all CRC cases in general, which may represent a genetically homogeneous subset of CRC.Entities:
Year: 2014 PMID: 24572700 PMCID: PMC3940837 DOI: 10.1038/ctg.2014.1
Source DB: PubMed Journal: Clin Transl Gastroenterol ISSN: 2155-384X Impact factor: 4.488
GIF results for subsets of CRC
| All CRC | 8,277 | <0.001 | NA |
| Early diagnosis (<50 years) | 682 | <0.001 | 0.001 |
| Distant stage at diagnosis | 1,527 | <0.001 | 0.35 |
| Grade at diagnosis (3 or 4) | 1,260 | 0.121 | 0.939 |
| CRC and ≥1 primary cancer of another site | 1,549 | <0.001 | 0.002 |
| Multiple independent primary CRCs | 270 | <0.001 | 0.003 |
| Long survival (>240 months) | 641 | 0.004 | 0.107 |
| Short survival (<10 months) | 1,918 | 0.009 | 0.964 |
| Under and normal weight (BMI <25 kg/m2) | 1,328 | 0.002 | 0.287 |
| Obese (BMI >30 kg/m2) | 858 | <0.001 | 0.073 |
BMI, body mass index; CRC, colorectal cancer; GIF, genealogic index of familiality; NA, not applicable.
For the analysis of all CRC cases, control sets were selected from the population. For all other subsets, controls were selected from the set of all CRC cases (SubsetGIF method).
Characteristics of 13 pedigrees containing a significant excess of colorectal cancer (CRC) and including multiple CRC cases with at least one other primary tumor at another site
| 3 | Breast, lip, stomach | 6 | 5 |
| 3 | Prostate | 5 | 5 |
| 3 | Breast, prostate, melanoma | 6 | 5 |
| 3 | Prostate, stomach | 5 | 5 |
| 3 | Prostate, thyroid, lip | 8 | 8 |
| 3 | Breast, prostate | 13 | 11 |
| 4 | Lip, prostate, stomach | 8 | 8 |
| 3 | Breast, prostate | 5 | 5 |
| 3 | Breast, prostate, lymphoma | 5 | 3 |
| 3 | Prostate, lymphoma, stomach | 3 | 3 |
| 3 | Breast, lymphoma, thyroid | 3 | 3 |
| 3 | Breast, gallbladder, bladder | 3 | 3 |
| 4 | Breast, prostate, lymphoma | 4 | 2 |
Not all CRC cases with at least one other primary tumor had samples available for genotyping.
Figure 1Genome-wide heterogeneity-TLOD scores for all pedigrees combined for general dominant (solid line) and recessive (dashed line) models.
Figure 2Representation of the pedigree with significant evidence for linkage at chromosome 22q11. Solid filled nodes indicate haplotype carriers diagnosed with colorectal cancer (CRC), and those with an asterisk indicate the CRC cases with primary tumors at other cancer sites. Sex has been intentionally obscured to prevent identification.